annual

EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders Meeting

EssilorLuxottica 2026 Annual Shareholders’ Meeting All resolutions proposed by the Board of Directors adoptedDividend of Euro 4.00 per share, with…

4 weeks ago

Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting

April 27, 2026 17:00 ET  | Source: Cabaletta Bio PHILADELPHIA, April 27, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq:…

4 weeks ago

ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

April 27, 2026 17:00 ET  | Source: ElevateBio – Posters detail large gene insertion and epigenetic editing capabilities, expanding ElevateBio’s…

4 weeks ago

Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

April 27, 2026 17:00 ET  | Source: Arbor Biotechnologies Inc - Oral presentation highlights novel compact RT editor demonstrating first…

4 weeks ago

Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm Society Meeting

April 23, 2026 12:00 ET  | Source: Catheter Precision, Inc. VIVO System to be featured in educational sessions at HRS…

1 month ago

Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting

Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic immunotherapies…

1 month ago

Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting

REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…

1 month ago

Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, April 19, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a…

1 month ago

OCI Global Publishes Notice of Annual General Meeting 2026

AMSTERDAM, April 17, 2026 /PRNewswire/ -- OCI Global (Euronext: OCI) ("OCI" or the "Company") today announces that it has published the…

1 month ago

Azerion Group publishes its 2025 Annual Report

Azerion Group publishes its 2025 Annual Report  Amsterdam, 17 April 2026 - Azerion Group N.V. (EURONEXT: AZRN) today published its audited…

1 month ago